Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC
Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand the effects (good and/or bad) of the addition of
RAD001 to standard radiation and chemotherapy (cisplatin and pemetrexed) for patients with
non-small cell lung cancer.